Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking | Zendy

Stephanie S. O’Malley | Zendy; Allen Zweben | Zendy; Lisa M. Fucito | Zendy; Ran Wu | Zendy; Mary Piepmeier | Zendy; David M. Ockert | Zendy; Krysten W. Bold | Zendy; Ismene Petrakis | Zendy; Srinivas B. Muvvala | Zendy; Peter Jatlow | Zendy; Ralitza Gueorguieva | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking

Author(s) -

Stephanie S. O’Malley,

Allen Zweben,

Lisa M. Fucito,

Ran Wu,

Mary Piepmeier,

David M. Ockert,

Krysten W. Bold,

Ismene Petrakis,

Srinivas B. Muvvala,

Peter Jatlow,

Ralitza Gueorguieva

Publication year - 2017

Publication title -

jama psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.531

H-Index - 365

eISSN - 2168-6238

pISSN - 2168-622X

DOI - 10.1001/jamapsychiatry.2017.3544

Subject(s) - medicine , varenicline , alcohol use disorder , smoking cessation , abstinence , placebo , randomized controlled trial , physical therapy , psychiatry , alcohol , biochemistry , chemistry , alternative medicine , pathology

Individuals with alcohol use disorder have high rates of cigarette smoking. Varenicline tartrate, an approved treatment for smoking cessation, may reduce both drinking and smoking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research